Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gagne

Showing results (71-80 of 344) with videos related to

Pageof 35
Sort By:
Drug Safety|November 14, 2016
Active Surveillance of Follow-on Biologics: A Prescription for UptakeAmeet Sarpatwari, Joshua J Gagne, Nicole L Levidow, et al.
Pharmacoepidemiology and Drug Safety|February 21, 2019
Quantifying bias reduction with fixed-duration versus all-available covariate assessment periodsJohn G Connolly, Sebastian Schneeweiss, Robert J Glynn, et al.
Physical Review Letters|October 4, 2005
Simulations of spinodal nucleation in systems with elastic interactionsC J Gagne, Harvey Gould, W Klein, et al.
Journal of Clinical Epidemiology|July 7, 2015
Measuring drug exposure: concordance between defined daily dose and days' supply depended on drug classSarah-Jo Sinnott, Jennifer M Polinski, Stephen Byrne, et al.
Pharmacoepidemiology and Drug Safety|January 24, 2020
Improving measurement of binary covariates in claims data: A simulation studyJohn G Connolly, Robert J Glynn, Sebastian Schneeweiss, et al.
American Heart Journal|December 28, 2020
Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort studyBenjamin N Rome, Joshua J Gagne, Jerry Avorn, et al.
Journal of the Autonomic Nervous System|June 1, 1990
Alpha 2-adrenoceptor modulation of catecholamine and neuropeptide Y responses during haemorrhagic hypotension in anaesthetized dogsR Briand, N Yamaguchi, J Gagne, et al.
American Journal of Epidemiology|October 27, 2016
Persistent User Bias in Case-Crossover Studies in PharmacoepidemiologyJesper Hallas, Anton Pottegård, Shirley Wang, et al.
Drug Safety|July 20, 2019
Non-Vitamin K Antagonist Oral Anticoagulants and Angioedema: A Cohort and Case-Crossover StudyJohn G Connolly, Sebastian Schneeweiss, Robert J Glynn, et al.
Epidemiology (Cambridge, Mass.)|March 8, 2013
Case-crossover studies of therapeutics: design approaches to addressing time-varying prognosis in elderly populationsShirley V Wang, Joshua J Gagne, Robert J Glynn, et al.
Pageof 35

Showing results (71-80 of 344) with videos related to

Sort By:
Pageof 35
Drug Safety|November 14, 2016
Active Surveillance of Follow-on Biologics: A Prescription for UptakeAmeet Sarpatwari, Joshua J Gagne, Nicole L Levidow, et al.
Pharmacoepidemiology and Drug Safety|February 21, 2019
Quantifying bias reduction with fixed-duration versus all-available covariate assessment periodsJohn G Connolly, Sebastian Schneeweiss, Robert J Glynn, et al.
Physical Review Letters|October 4, 2005
Simulations of spinodal nucleation in systems with elastic interactionsC J Gagne, Harvey Gould, W Klein, et al.
Journal of Clinical Epidemiology|July 7, 2015
Measuring drug exposure: concordance between defined daily dose and days' supply depended on drug classSarah-Jo Sinnott, Jennifer M Polinski, Stephen Byrne, et al.
Pharmacoepidemiology and Drug Safety|January 24, 2020
Improving measurement of binary covariates in claims data: A simulation studyJohn G Connolly, Robert J Glynn, Sebastian Schneeweiss, et al.
American Heart Journal|December 28, 2020
Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort studyBenjamin N Rome, Joshua J Gagne, Jerry Avorn, et al.
Journal of the Autonomic Nervous System|June 1, 1990
Alpha 2-adrenoceptor modulation of catecholamine and neuropeptide Y responses during haemorrhagic hypotension in anaesthetized dogsR Briand, N Yamaguchi, J Gagne, et al.
American Journal of Epidemiology|October 27, 2016
Persistent User Bias in Case-Crossover Studies in PharmacoepidemiologyJesper Hallas, Anton Pottegård, Shirley Wang, et al.
Drug Safety|July 20, 2019
Non-Vitamin K Antagonist Oral Anticoagulants and Angioedema: A Cohort and Case-Crossover StudyJohn G Connolly, Sebastian Schneeweiss, Robert J Glynn, et al.
Epidemiology (Cambridge, Mass.)|March 8, 2013
Case-crossover studies of therapeutics: design approaches to addressing time-varying prognosis in elderly populationsShirley V Wang, Joshua J Gagne, Robert J Glynn, et al.
Pageof 35